- Previous Close
3,490.00 - Open
3,410.00 - Bid 3,330.00 x --
- Ask 3,390.00 x --
- Day's Range
3,325.00 - 3,480.00 - 52 Week Range
2,755.00 - 4,645.00 - Volume
3,700 - Avg. Volume
1,695 - Market Cap (intraday)
8.008B - Beta (5Y Monthly) 0.06
- PE Ratio (TTM)
8.86 - EPS (TTM)
375.96 - Earnings Date Feb 7, 2025
- Forward Dividend & Yield 155.00 (4.44%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
--
WDB coco Co., Ltd. provides contract services to pharmaceutical companies in Japan. The company supports the development of pharmaceuticals and medical devices with a focus on safety information management; safety information management support; clinical research support; and post-marketing safety information management operations services. It also provides support for the preparation of various translation, and QC; clinical research support; and manpower dispatch services. In addition, the company offers post-marketing surveillance (PMS) services, such as contract conclusion with medical facilities, survey explanations, receipt of survey forms, monitoring services, including conducting re-surveys, case registration center, data management, and statistical analysis. WDB coco Co., Ltd. was incorporated in 1984 and is headquartered in Tokyo, Japan.
www.wdbcoco.com504
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: 7079.T
View MorePerformance Overview: 7079.T
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7079.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7079.T
View MoreValuation Measures
Market Cap
8.01B
Enterprise Value
5.38B
Trailing P/E
8.45
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.59
Price/Book (mrq)
2.08
Enterprise Value/Revenue
1.07
Enterprise Value/EBITDA
3.71
Financial Highlights
Profitability and Income Statement
Profit Margin
18.05%
Return on Assets (ttm)
18.85%
Return on Equity (ttm)
25.71%
Revenue (ttm)
5.21B
Net Income Avi to Common (ttm)
941M
Diluted EPS (ttm)
375.96
Balance Sheet and Cash Flow
Total Cash (mrq)
3.22B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--